Skip to content

Clinical trial to evaluate the efficacy of Ayurvedic intervention in Dadru Kushta with special reference to Dermatophytosis.

Randomised controlled clinical trial to evaluate the efficacy of Ayurvedic Intervention in DADRU KUSHTHA with special reference to Dermatophytosis. - NILL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092287
Enrollment
60
Registered
2025-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

National Institute of Ayurveda Deemed to be university DENOVO Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing to participate in clinical trial and provide informed consent. 2.The patients fullfilling the diagnostic criteria of Dadru Kushtha lakshanas such as- A. Kandu (itching) B. Raga(erythma) C. Pidika(eruptions) D. Utasanna mandala(elevated circular lesions) 3.Patients with chronocity of illness less than five years.

Exclusion criteria

Exclusion criteria: 1.Patients with long-term history of steroid and cytotoxic treatment. 2.History of hypersensitivity or allergy to study drugs. 3.Patients having concomitant illness like uncontrolled Hypertension, Diabetes Mellitus and known case of HIV, Malignancy. 4.Patients having other associated skin disease like eczema, secondary bacterial infection, etc. 5.Patient participated in any clinical trial with in last six months. 6.Presence of any other serious medical condition that may interfere with study participation. 7.Severe renal Impairment.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be relief in kandu (itching) at the end of the treatment period.Timepoint: Baseline to the end of the treatment period.

Secondary

MeasureTime frame
Secondary outcomes will include changes in subjective & objective parameters such as kandu(itching), Raga(erythema), Pidika (eruptions) & Utasanna mandala (elevated circular skin lesion). - Changes in QOL using the DLQI [Dermatology Life Quality Index .Timepoint: Baseline, 21st day & 42th day(end of the treatment period).

Countries

India

Contacts

Public ContactDr Pravin Shamrao Sawant

National Institute of Ayurveda

Svanika18@gmail.com7987376490

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026